Corrigendum to “Resveratrol ameliorates diabetic encephalopathy through PDE4D/PKA/Drp1 signaling” [Brain Res. Bull. 203 (2023) 110763]
Yanjuan Cao,
Wen Sun,
Chang Liu,
Zihui Zhou,
Zongli Deng,
Mingjie Zhang,
Meng Yan,
Xiaoxing Yin,
Xia Zhu
Affiliations
Yanjuan Cao
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Wen Sun
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Chang Liu
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Zihui Zhou
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Zongli Deng
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Mingjie Zhang
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Meng Yan
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Xiaoxing Yin
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
Xia Zhu
Correspondence to: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province 221004, China.; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China
